WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth

Nav: ₹ 14.100 ↑ 1.3%
[as on 1 October, 2025]

Nav chart with SMA (Simple moving average) overlay

SMA (Simple Moving Average)

  • 100 SMA
  • 200 SMA
  • 300 SMA
  • 400 SMA
  • 500 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth 0.66% 1.3% 1.3% -0.56% 1.64% 7.05%----

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
89.71% 3.01% (Arbitrage: 0.00%) 0.00% 0.00% 7.28%

Equity

NameSectorWeight %
Max Healthcare Institute LimitedHealthcare Services6.99%
JB Chemicals & Pharmaceuticals LimitedPharmaceuticals & Biotechnology6.80%
Fortis Healthcare LimitedHealthcare Services6.27%
Sun Pharmaceutical Industries LimitedPharmaceuticals & Biotechnology6.09%
Cipla LimitedPharmaceuticals & Biotechnology4.92%
Laurus Labs LimitedPharmaceuticals & Biotechnology4.21%
Krishna Institute Of Medical Sciences LimitedHealthcare Services3.81%
Apollo Hospitals Enterprise LimitedHealthcare Services3.27%
Vijaya Diagnostic Centre LimitedHealthcare Services2.61%
Neuland Laboratories LimitedPharmaceuticals & Biotechnology2.53%
Anthem Biosciences LimitedPharmaceuticals & Biotechnology2.42%
Abbott India LimitedPharmaceuticals & Biotechnology2.30%
Divi's Laboratories LimitedPharmaceuticals & Biotechnology2.28%
Thyrocare Technologies LimitedHealthcare Services2.28%
Sai Life Sciences LimitedPharmaceuticals & Biotechnology2.25%
Shaily Engineering Plastics LimitedIndustrial Products1.94%
Gland Pharma LimitedPharmaceuticals & Biotechnology1.90%
Kovai Medical Center and Hospital LimitedHealthcare Services1.78%
Glenmark Pharmaceuticals LimitedPharmaceuticals & Biotechnology1.67%
Emcure Pharmaceuticals LimitedPharmaceuticals & Biotechnology1.65%
Piramal Pharma LimitedPharmaceuticals & Biotechnology1.64%
GlaxoSmithKline Pharmaceuticals LimitedPharmaceuticals & Biotechnology1.62%
Ajanta Pharma LimitedPharmaceuticals & Biotechnology1.58%
Jupiter Life Line Hospitals LimitedHealthcare Services1.55%
Eris Lifesciences LimitedPharmaceuticals & Biotechnology1.53%
Lupin LimitedPharmaceuticals & Biotechnology1.33%
Pfizer LimitedPharmaceuticals & Biotechnology1.29%
Alembic Pharmaceuticals LimitedPharmaceuticals & Biotechnology1.21%
AstraZeneca Pharma India LimitedPharmaceuticals & Biotechnology1.14%
Acutaas Chemicals LimitedPharmaceuticals & Biotechnology1.05%
Shilpa Medicare LimitedPharmaceuticals & Biotechnology0.83%
Navin Fluorine International LimitedChemicals & Petrochemicals0.80%
Dr.Agarwals Eye Hospital LimitedHealthcare Services0.76%
Healthcare Global Enterprises LimitedHealthcare Services0.67%
Poly Medicure LimitedHealthcare Equipment & Supplies0.64%
Supriya Lifescience LimitedPharmaceuticals & Biotechnology0.64%
PB Fintech LimitedFinancial Technology (Fintech)0.55%
Zota Health Care LimitedPharmaceuticals & Biotechnology0.50%
Orchid Pharma LimitedPharmaceuticals & Biotechnology0.49%
Onesource Specialty Pharma LimitedPharmaceuticals & Biotechnology0.45%
Jubilant Ingrevia LimitedChemicals & Petrochemicals0.44%
Mankind Pharma LimitedPharmaceuticals & Biotechnology0.41%
Aster DM Healthcare LimitedHealthcare Services0.38%
Laxmi Dental LimitedHealthcare Equipment & Supplies0.24%

Debt

NameRatingWeight %
91 Days Tbill (MD 02/10/2025)Sovereign1.18%
182 Days Tbill (MD 04/09/2025)Sovereign0.47%
364 Days Tbill (MD 03/10/2025)Sovereign0.47%
91 Days Tbill (MD 30/10/2025)Sovereign0.28%
91 Days Tbill (MD 20/11/2025)Sovereign0.23%
91 Days Tbill (MD 25/09/2025)Sovereign0.12%
91 Days Tbill (MD 16/10/2025)Sovereign0.12%
182 Days Tbill (MD 23/10/2025)Sovereign0.09%
91 Days Tbill (MD 23/10/2025)Sovereign0.05%
Portfolio data is as on date 31 August, 2025

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?
    The latest NAV of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth is 14.100 as on 1 October, 2025.
  • What are YTD (year to date) returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?
    The YTD (year to date) returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth are 0.66% as on 1 October, 2025.
  • What are 1 year returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth?
    The 1 year returns of WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth are 7.05% as on 1 October, 2025.